Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases

Current Drug Targets
Arunaksharan Narayanankutty

Abstract

Toll-like receptors (TLR) are one among the initial responders of the immune system which participate in the activation inflammatory processes. Several different types of TLR such as TLR2, TLR4, TLR7 and TLR9 have been identified in various cell types, each having distinct ligands like lipids, lipoproteins, nucleic acids and proteins. Though its prime concern is xenobiotic defences, TLR signalling has also recognized as an activator of inflammation and associated development of chronic degenerative disorders (CDDs) including obesity, type 2 diabetes mellitus (T2DM), fatty liver disease, cardiovascular and neurodegenerative disorders as well as various types of cancers. Numerous drugs are in use to prevent these disorders, which specifically inhibit different pathways associated with the development of CDDs. Compared to these drug targets, inhibition of TLR, which specifically responsible for the inflammatory insults has proven to be a better drug target. Several natural products have emerged as inhibitors of CDDs, which specifically targets TLR signalling, among these, many are in the clinical trials. This review is intended to summarize the recent progress on TLR association with CDDs and to list possible use of natural produc...Continue Reading

References

Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·F TakeshitaD M Klinman
Jun 5, 2004·Journal of Leukocyte Biology·Min-Fu Tsan, Baochong Gao
Mar 31, 2007·The Journal of Biological Chemistry·John Hiscott
Nov 6, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Silke WalterKlaus Fassbender
Dec 12, 2007·Handbook of Experimental Pharmacology·Satoshi Uematsu, Shizuo Akira
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Malabendu JanaKalipada Pahan
Dec 5, 2008·Nature Reviews. Cancer·Seth Rakoff-Nahoum, Ruslan Medzhitov
Feb 13, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Henrieta ScholtzovaThomas Wisniewski
Jan 12, 2010·Current Opinion in Immunology·Anne F McGettrick, Luke A J O'Neill
Jul 16, 2010·Mediators of Inflammation·F ArslanA E Parker
Jul 16, 2010·Journal of Cellular and Molecular Medicine·Li YuShangwu Chen
Sep 22, 2010·Diabetes·Shanshan PangYingying Le
Nov 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hailing LuMary L Disis
Apr 13, 2011·Structure·Istvan BotosDavid R Davies
Nov 4, 2011·Cellular and Molecular Life Sciences : CMLS·Li YuShangwu Chen
Dec 27, 2011·Trends in Biochemical Sciences·Monique Gangloff
Dec 27, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shirong LiuKlaus Fassbender
Jan 14, 2012·Journal of Medicinal Chemistry·Nikunj M ShuklaSunil A David
Feb 11, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wei ZhaoChengjiang Gao
Mar 10, 2012·The Journal of Nutritional Biochemistry·Yong Sook KimYoungkeun Ahn
Jun 12, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Chuan-tao TuShun-cai Zhang
Nov 14, 2012·Phytotherapy Research : PTR·Dev S ChahalMohan R Dasu
Feb 1, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Suaad AhmedSinead M Miggin
Mar 20, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jianzhong ZhuSaumendra N Sarkar
Jul 9, 2013·The Journal of Endocrinology·Mohamed Asrih, François R Jornayvaz
Aug 6, 2013·Immunology·Renzo Perales-Linares, Sonia Navas-Martin
Sep 3, 2013·Human Immunology·Paulina WłasiukKrzysztof Giannopoulos

❮ Previous
Next ❯

Citations

May 1, 2019·Nutrients·Lucia Malaguarnera
Jun 13, 2020·Nutrition and Cancer·Arunaksharan NarayanankuttyAchuthan C Raghavamenon
Jul 28, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Piao ZhengYang Wang
Dec 15, 2020·Drug and Chemical Toxicology·Dhilna MalayilArunaksharan Narayanankutty
Jul 23, 2020·Current Pharmaceutical Design·Arunaksharan NarayanankuttyJoice T Job
Sep 12, 2020·Recent Patents on Anti-cancer Drug Discovery·Arunaksharan Narayanankutty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
Wilson J Chang, Luis H Toledo-Pereyra
Trends in Pharmacological Sciences
Brian Keogh, Andrew E Parker
© 2022 Meta ULC. All rights reserved